Prähospitale Lyse und Akut-PTCA beim akuten Myokardinfarkt mit ST-Hebungen

Zusammenfassung

Der akute Myokardinfarkt mit ST-Hebungen stellt eine der Haupttodesursachen in den westlichen Industriestaaten dar. Das primäre Therapieziel liegt in der raschen Wiedereröffnung des verschlossenen Herzkranzgefäßes. Dies kann entweder durch eine prähospitale Lyse oder eine Akut-PTCA (perkutane transluminale Koronarangioplastie) erreicht werden. Bisherige Studien, die eine prähospitale Lyse mit einer Akut-PTCA verglichen haben, zeigen teilweise uneinheitliche Ergebnisse. Im Rahmen dieser Übersichtsarbeit soll die aktuelle Studienlage beleuchtet werden und auf die geltenden Leitlinien zur Behandlung des akuten Infarktes mit ST-Streckenhebungen eingegangen werden. Zudem werden Wirkmechanismus, Voraussetzungen sowie Kontraindikationen für eine prähospitale Lyse erläutert.

Abstract

Acute ST-elevation myocardial infarctions are one of the major causes for morbidity and mortality in the industrial world. Rapid reopening of the occluded coronary vessel is the major goal in this setting. Prehospital lysis and acute PCI (percutaneous coronary intervention) are two alternatives to obtain this goal. Studies comparing prehospital lysis with acute PCI have shown inconsistent results. This review tries to elucidate current studies and guidelines for the treatment of acute ST-elevation myocardial infarctions. Additionally, mechanisms, indications and contraindications for prehospital lysis are discussed.

Prähospitale Lyse - ST-Hebungsinfarkt - Akut-PTCA

Prehospital lysis - ST-elevation myocardial infarction - acute PCI

Literatur

• 1 The World Health Report 2003 Statistical Annex. Ref Type: Report,. 2003
• 2 The European Myocardial Infarction Project Group . Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.  N Engl J Med. 1993;  329 383-389
• 3 Weaver W D, Cerqueira M, Hallstrom A P. et al . Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial.  JAMA. 1993;  270 1211-1216
• 4 Statistik NAW 2505 1995 - 2000. Ref Type: Internet Communication,. http://www.charite.de/rv/nephro/Notruf/nawstatist.html 2004
• 5 Raitt M H, Maynard C, Wagner G S. et al . Relation between symptom duration before thrombolytic therapy and final myocardial infarct size.  Circulation. 1996;  93 48-53
• 6 Luca G De, Hof A W van't, Boer M J de. et al . Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.  Eur Heart J. 2004;  25 1009-1013
• 7 Kastrati A, Mehilli J, Nekolla S. et al . A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.  J Am Coll Cardiol. 2004;  43 734-741
• 8 Naghavi M, Libby P, Falk E. et al . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.  Circulation. 2003;  108 1772-1778
• 9 Werner G S. Optimale Lysestrategien bei akutem Herzinfarkt: Trotzdem perkutane Koronarintervention (PCI)?.  Dtsch Med Wochenschr. 2003;  128 2149-2152
• 10 Collins R, Peto R, Baigent C. et al . Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.  N Engl J Med. 1997;  336 847-860
• 11 Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) . Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.  Lancet. 1986;  1 397-402
• 12 Tanswell P, Modi N, Combs D. et al . Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.  Clin Pharmacokinet. 2002;  41 1229-1245
• 13 Assessment of the Safety and Efficacy of a New Thrombolytic Investigators . Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.  Lancet. 1999;  354 716-722
• 14 Hanania G, Cambou J P, Gueret P. et al . Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry.  Heart. 2004;  90 1404-1410
• 15 Hamm C W. Guidelines: Acute coronary syndrome. (ACS) II: Acute coronary syndrome with ST-elevation.  Z Kardiol. 2004;  93 324-341
• 16 Danchin N, Vaur L, Genes N. et al . Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the „real world”: one-year results from a nationwide French survey.  Circulation. 1999;  99 2639-2644
• 17 Danchin N, Blanchard D, Steg P G. et al . Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.  Circulation. 2004;  110 1909-1915
• 18 Morrison L J, Verbeek P R, McDonald A C. et al . Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.  JAMA. 2000;  283 2686-2692
• 19 Steg P G, Bonnefoy E, Chabaud S. et al . Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.  Circulation. 2003;  108 2851-2856
• 20 Bonnefoy E, Steg P G, Chabaud S. et al .Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial. Eur Heart J 2005 [Epub ahead of print]
• 21 Widimsky P, Budesinsky T, Vorac D. et al . Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2.  Eur Heart J. 2003;  24 94-104
• 22 Werf F Van de, Ardissino D, Betriu A. et al . Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.  Eur Heart J. 2003;  24 28-66
• 23 Andersen H R, Nielsen T T, Rasmussen K. et al . A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.  N Engl J Med. 2003;  349 733-742
• 24 Hudson M P, Granger C B, Topol E J. et al . Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.  Circulation. 2001;  104 1229-1235
• 25 Shufelt K A, Paradiso-Hardy F L, Papastergiou J. et al . High mortality with ST elevation myocardial infarction in a nontrial setting.  Can J Cardiol. 2004;  20 1455-1459
• 26 Rawles J. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).  J Am Coll Cardiol. 1994;  23 1-5